Back to rounds

Company profile

Allogenetics

Allogenetics provides a unique solution to the problem of organ rejection following transplantation.

Location
Hanover, Niedersachsen, Germany, Europe
Website
allogenetics.de

Latest known funding

Seed round

Capital
$4.4M
Announced
Sep 9, 2026